CClinicalTrials.gg
CompletedNCT04308772Updated Mar 16, 2020

Web-Based Physiotherapy Following Knee Arthroscopy

An interventional study of Web-based Physiotherapy in Knee Arthroscopy and Physical Therapy, sponsored by Glasgow Caledonian University. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-03-16.

Sponsored by Glasgow Caledonian University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jun 2018, registered Mar 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Web-based physiotherapy might improve care following knee arthroscopy. For this study half of the participants will receive usual care (printed leaflet) and half will receive 6 weeks of web-based physiotherapy.

Read the detailed description

Despite its minimally invasive nature, studies have shown that patients undergoing arthroscopic meniscectomy have pain, effusion, loss of range of motion, functional, neuromuscular and biomechanical changes, loss of quadriceps muscle strength, and a reduced quality of life (Durand et al.,1993;Goodwin and Morrissey,2003; Glatthorn et al.,2010). With changes in service delivery patients following arthroscopy only receive a printed leaflet. Web-based physiotherapy may offer offer cost effective support to patients. Therefore, the aim of this study is to undertake a single blind, randomised controlled pilot study examining the effectiveness of a six week web-based physiotherapy programme compared to usual care alone, for people following knee arthroscopy and to gather essential information for the planning of a definitive trial.

02

Conditions studied

  • Knee Arthroscopy
  • Physical Therapy

Keywords

  • knee
  • arthroscopy
  • physiotherapy
  • web-based
03

In context

Lead sponsor

Glasgow Caledonian University is the lead sponsor of 45 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients who have undergone Knee Arthroscopy surgery.
  • Access to a personal computer/tablet or smart phone with an email address and internet connection
  • Be able to understand English.

Exclusion criteria

Exclusion Criteria:

  • Infection or other post-operative complications
  • Other significant co-morbidities for which exercise is contra-indicated
  • Unwilling to be randomised to intervention/control group
  • Taking part in another research project
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
33 participants (actual)

Study arms

  • No intervention
    Usual Care

    Those randomised to the usual care arm will receive a leaflet which contains a standard programme of exercises Participants will be asked to complete their exercise programme as prescribed (at least once per day).

  • Experimental
    Web-based physiotherapy

    Participants will receive a six week exercise programme, based on those in the usual care exercise sheet delivered via the web-based physio website (www.giraffehealth.com).

    Behavioral: Web-based Physiotherapy

Interventions

  • BehavioralWeb-based Physiotherapy

    Participants will receive an exercise programme, based on those patients usually get in the form of an exercise leaflet, delivered via a web-based physio website (www.giraffehealth.com). Participants will be asked to complete their exercise programme as prescribed (at least once each day) and to fill out an online exercise diary which the physiotherapist can see remotely from the clinical site.

06

What researchers measure

Primary outcomes

  1. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS).

    The KOOS is a patient reported outcome measure, developed to assess the patients' opinion about their knee and associated problems. The KOOS evaluates both short-term and long-term consequences of knee injury. It consists of 42 items in 5 separately scored subscales; Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL).The KOOS is self-administered and takes approximately 10 minutes to complete. The KOOS is reliable, responsive to surgery and physical therapy and can be used to evaluate the course of knee injury and treatment outcomes (Roos et al.,1998).

    Time frame: Baseline to 6 weeks.

Secondary outcomes

  1. Change in Cincinnati Sports Activity Scale (CSAS)

    CSAS is a patient reported outcome measure, developed to assess the patients' sports participation and identify patients who experience symptoms during athletic activities. It consists of 16 items in 5 separately scored subscales; the frequency of participation, the knee functions that occur during various sports activities and activities of daily living, the change that occurs in activity levels between treatment periods and the problems patients encounter with individual sports that place varying loads on the knee joint. The CSAS is self-reported and takes approximately 6 minutes to complete. The CSAS is reliable, valid and responsive and can be used to evaluate the sports activity levels and participation (Noyes et al., 1989).

    Time frame: Baseline to 6 weeks.

  2. Adherence to exercise programme

    Participants are advised to undertake their exercise programme at least once per day for six weeks and adherence will be based on the mean number of completed entries in exercise diaries over the 6 weeks of the programme and the total adherence to the programme will be calculated as a percentage.

    Time frame: Weekly for 6 weeks

  3. Health Resource Form

    a form detailing the number of interactions with health care professionals, such as physiotherapy and GP visits and medication use during the study.

    Time frame: Week 6

07

Study locations

1 site
  • Queen Elizabeth University Hospital
    Glasgow, G51 4TF, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04308772
Lead sponsor
Glasgow Caledonian University
Collaborators
NHS Greater Glasgow and Clyde
Responsible party
Sponsor
First posted
Mar 16, 2020
Start date
Jun 25, 2018
Primary completion
Oct 29, 2018
Completion
Dec 31, 2018
Last update
Mar 16, 2020

Study contacts

Spiros Nikologiannis
principal investigator · Glasgow Caledonian University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion